Ann: FDA Outlines Pathway to Accelerated Approval for MPL in MND, page-58

Good luck with your investments, must admit I cashed out of a few options to free carry at .06c the rest are firmly held. As stated earlier I will be probably taking the lead from Our CEO and BoD re. exercising them.

When the same returns present themselves for the shares I may consider the same action but I doubt it. Lets face it the top line results for last years fully funded Fight MND's trial would be about the worst kept secret in the market in a long time. The FDA's approval for orphan and rare disease appear to be
"imminent".

Most of the top 100 share holders have bought on the "rumour", the story has just begun we are not even up to the "once upon time there was a penny dreadful company called PAA " yet.
The top 100 hold about 60% of available shares and if anything seem to be growing their holdings. Anyway I wish the traders good luck and hope they make a good margin along the way.

Good luck to all